Semaglutide Tablets vs Drops vs ODTs: Route, Format, and Price Guide

Last reviewed: September 21, 2026 Last updated: September 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Semaglutide is available in multiple oral and sublingual forms: tablets designed to dissolve under the tongue (sublingual), orally dissolving tablets (ODTs) that disintegrate on the tongue, liquid drops placed under the tongue, and traditional oral capsules swallowed whole. The absorption path differs—sublingual and ODT forms bypass the digestive tract, while swallowed tablets and capsules absorb through the gastrointestinal system. Pricing for these compounded oral forms spans $149–$289 per month on a recurring month-to-month basis across six major telehealth providers; prepaid multi-month plans can reduce the effective monthly cost to $149–$199. Every compounded oral semaglutide option is formulated by 503A compounding pharmacies, is not FDA-approved, and requires a licensed clinician to determine appropriateness for the individual patient. PlexusDx compounded semaglutide oral capsules (swallowed) cost $289 per month month-to-month, $269 on a three-month plan, or $249 on six months, all-inclusive with no membership fee and the same price at every dose.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies.

At-a-glance: Oral and sublingual semaglutide formats

Table captures month-to-month refill or standard recurring rates; first-month introductory and prepaid-in-full figures appear in the normalization section below. All prices verified September 4, 2026, except PlexusDx (July 23, 2026). Compounded semaglutide oral forms are distinct from FDA-approved brand Wegovy pill (rybelsus active mechanism, marketed for diabetes and weight). MEDVi tablet surcharge applies on top of semaglutide injection refill price.

Clinical format distinctions: absorption routes explained

Semaglutide oral and sublingual formats share the same GLP-1 receptor agonist mechanism but differ in how the medication enters the bloodstream:

• Sublingual tablets and drops dissolve or are held under the tongue, allowing absorption through the mucous membrane directly into capillaries, bypassing the digestive tract and first-pass hepatic metabolism.
• Orally dissolving tablets (ODTs) disintegrate on the tongue and are swallowed with saliva; the medication absorbs through the gastrointestinal tract.
• Oral capsules and swallowed tablets transit the stomach and absorb in the small intestine, subject to digestive enzymes and first-pass liver metabolism.

Compounded formulations use absorption enhancers (such as sodium caprate in some compounded sublingual forms) to improve bioavailability. The FDA-approved brand oral semaglutide (marketed as Rybelsus for type 2 diabetes, and more recently as Wegovy pill for weight management) uses the absorption enhancer SNAC (salcaprozate sodium) and requires specific fasting administration instructions to achieve therapeutic levels. Compounded oral and sublingual semaglutide formulations are distinct from these brand products, are not FDA-approved, and do not undergo the same pre-market safety, efficacy, and quality review.

A licensed clinician determines whether a compounded oral or sublingual formulation is appropriate for an individual patient based on medical history, tolerance, and treatment goals. Some patients report preferring sublingual formats to avoid gastrointestinal side effects associated with swallowed GLP-1 medications; others find capsules more convenient for daily routine. Clinical evidence for compounded oral and sublingual semaglutide is limited compared to the FDA-approved injection and brand oral tablet, and outcomes may vary by formulation and individual absorption.

Like-for-like pricing: month-to-month and prepaid plans normalized

Oral and sublingual semaglutide pricing structures differ significantly across providers. Some publish a single recurring rate; others use introductory discounts or prepaid-in-full plans that lower the effective monthly cost. The table below compares ongoing month-to-month rates and calculates the true 12-month cost including any first-month promotions or prepaid commitments.

All calculations are ours and assume continuous monthly treatment over 12 months. Henry Meds prepaid-in-full (PIF) prices require upfront payment of the full term. MEDVi tablet surcharge verified at checkout September 4, 2026; first-month introductory rate applies to injection base. Eden membership and medication are billed separately; membership first month $39 (introductory rate), then $99/month; medication $99/month. PlexusDx six-month and three-month plans bill the term total upfront. Prices captured September 4, 2026, except PlexusDx (July 23, 2026). Confirm all figures at provider checkout; promotional and prepaid rates may change.

Decision factors: format, convenience, and cost structure

Absorption route and tolerability. Sublingual tablets and drops may offer faster initial absorption and reduced exposure to gastrointestinal enzymes, which some patients associate with fewer GI side effects (nausea, vomiting, diarrhea). Oral capsules and swallowed tablets transit the stomach and are subject to digestive breakdown and first-pass liver metabolism. Individual response varies, and clinical evidence for compounded formulations is limited. A licensed provider can help assess which route aligns with your tolerance and medical history.

Dosing and administration. Sublingual formats require holding the tablet or drops under the tongue for a specified time (often 60–90 seconds) without swallowing, eating, or drinking. Oral capsules are swallowed with water, similar to any daily medication. FDA-approved brand oral semaglutide (Rybelsus, Wegovy pill) requires fasting administration—taken on an empty stomach with a small amount of water, followed by a 30-minute wait before eating—to achieve bioavailability; compounded oral capsules may have different instructions set by the prescribing clinician and compounding pharmacy.

Price transparency and predictability. PlexusDx and Henry Meds publish single recurring prices with no dose-based increases; MEDVi and Eden use a base medication price plus separate fees (MEDVi's $70 tablet surcharge, Eden's separate membership). Prepaid-in-full plans (Henry Meds 12-month at $1,788, a per-month rate of $149, our calculation) require upfront commitment and payment, which lowers the effective monthly rate but removes month-to-month flexibility. First-month introductory rates (MEDVi semaglutide injection $179 introductory, refill $299, plus $70 tablet surcharge in both months) create a lower entry cost but higher ongoing expense.

Membership and bundled services. Eden charges medication and membership separately ($99 each per month, $198 total, after the first month's $39 introductory membership rate), with membership covering clinician access, coaching, and support. PlexusDx, Henry Meds, and MEDVi bundle provider visit, medication, and shipping into a single published price with no separate membership fee. Providers offering branded Wegovy pill (Ro, WeightWatchers Clinic, LifeMD) separate the clinical program membership from medication cost; for example, Ro Body Program costs $149/month for the clinical program, and Wegovy pill medication cost begins at $149/month, creating a combined entry point starting at $298/month (or lower with prepaid membership plans).

Brand vs compounded distinction. FDA-approved brand oral semaglutide (Wegovy pill, Rybelsus) underwent pre-market clinical trials and regulatory review for safety, efficacy, and manufacturing quality. Compounded oral and sublingual semaglutide—offered by Henry Meds, MEDVi, PlexusDx, ShedRx, and Eden—are formulated by 503A compounding pharmacies for individual patients and are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a compounded or brand product is appropriate for each patient.

Choose Henry Meds sublingual semaglutide if…

You prefer a sublingual route to bypass the digestive tract, you are willing to commit to a 12-month prepaid plan to access a $149/month effective rate ($1,788 paid in full upfront, our calculation), and you want an all-inclusive package with no separate membership. Henry Meds offers both a standard sublingual tablet at $249/month month-to-month and a "premium" tablet/drops option at $179/month month-to-month, with the same $1,788 prepaid 12-month total for both formats. The prepaid plan requires full upfront payment and removes monthly billing flexibility. Henry Meds also provides compounded semaglutide injection at $297/month month-to-month or $2,364 prepaid 12-month ($197/month equivalent, our calculation), allowing a switch between routes if tolerability or preference changes. All Henry Meds compounded products are formulated by 503A pharmacies, are not FDA-approved, and include medication, provider visit, and shipping in the published price (captured September 4, 2026).

Choose MEDVi semaglutide tablet if…

You are already on or considering MEDVi compounded semaglutide injection and want to add an oral tablet option, you accept the $70/month surcharge on top of the injection price, and you value the first-month entry discount ($179 introductory injection rate + $70 tablet = $249 first month, then $299 injection refill + $70 = $369/month refill). MEDVi tablet pricing adds to the injection base, so the oral option costs more than the injection alone. The combined 12-month cost of MEDVi tablet is $4,308 (our calculation: $249 first month + $369×11), which is higher than standalone oral options from Henry Meds prepaid or Eden. MEDVi publishes that dose increases do not raise the price, offering predictability as titration progresses. MEDVi works with 503A compounding pharmacies, and the compounded tablet is not FDA-approved. Pricing verified at checkout September 4, 2026; no membership fee; monthly billing, cancel anytime.

Choose Eden oral semaglutide if…

You want the lowest recurring monthly rate in the comparison ($99 medication + $99 membership = $198/month after the first month's $39 introductory membership rate) and you value integrated coaching, labs, and clinician support included in the membership. Eden's 12-month total is $2,316 (our calculation: $138 first-month introductory total + $198×11 refill), the lowest in this comparison for month-to-month billing without prepayment. The oral route and exact format (tablet, capsule, or sublingual) are clinician-dependent and may vary by state and availability. Eden separates medication and membership billing; both recur monthly. The compounded semaglutide is formulated by 503A pharmacies, is not FDA-approved, and a licensed clinician determines appropriateness. Pricing captured September 4, 2026.

Choose PlexusDx oral semaglutide if…

You want a straightforward oral capsule (swallowed, GI absorption) with one published price that never changes by dose, no membership fee, and flexible plan length. PlexusDx compounded semaglutide oral capsules cost $289/month month-to-month, $269/month on a three-month plan, or $249/month on a six-month plan—all prices include the provider visit, prescription, medication, and shipping. The six-month plan delivers a 12-month cost of $2,988 (our calculation: two six-month cycles at $249/month), which sits between Eden's $2,316 (first-month introductory total plus refill rates) and Henry Meds' month-to-month $2,988 but is lower than MEDVi's $4,308 tablet surcharge model. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). PlexusDx works with licensed 503A compounding pharmacies; compounded medications are not FDA-approved, and a licensed clinician determines whether a prescription is appropriate for the individual patient. Pricing captured July 23, 2026; confirm at checkout.

Brand oral semaglutide (Wegovy pill): a different product class

FDA-approved brand oral semaglutide—marketed as Wegovy pill for weight management and Rybelsus for type 2 diabetes—is a distinct product from compounded oral and sublingual formulations. Wegovy pill uses the absorption enhancer SNAC (salcaprozate sodium) and requires specific fasting administration: taken once daily on an empty stomach with up to 4 ounces of water, followed by a 30-minute wait before eating, drinking, or taking other medications. This protocol is necessary to achieve therapeutic semaglutide levels, as oral bioavailability without an enhancer is very low.

Ro, WeightWatchers Clinic, and LifeMD offer access to brand Wegovy pill through their platforms. Pricing for the medication begins at $149/month at the lowest dose (captured September 4, 2026), with higher doses up to $299/month. These medication costs are separate from the clinical program membership: Ro Body Program costs $149/month (or $89/month on a six-month prepaid plan, $74/month on 12-month prepaid, both our calculation), WeightWatchers Clinic Med+ costs $25/month for the first two months (promotional introductory rate, 12-month commitment) then $74/month, and LifeMD membership costs $39 first month (introductory rate) then $149/month. The combined monthly cost of membership plus medication ranges from $198 to $448, depending on provider, plan, and dose.

Brand Wegovy pill is FDA-approved, supported by clinical trial data for safety and efficacy, and manufactured under FDA-regulated Good Manufacturing Practices (GMP). Compounded oral and sublingual semaglutide are not FDA-approved, do not undergo the same pre-market review, and are formulated by 503A compounding pharmacies for individual patients. A licensed clinician determines whether a brand or compounded product is appropriate based on medical history, insurance coverage, cost, and treatment goals.

Strengths and gaps across oral semaglutide options

Henry Meds offers the lowest effective monthly rate when prepaid ($149/month over 12 months, $1,788 upfront, our calculation) and provides both sublingual tablet and premium tablet/drops formats. The prepaid model removes monthly flexibility and requires full payment at enrollment; month-to-month rates ($249 or $179) are higher and competitive with PlexusDx. No dose-based price increases. Compounded, 503A, not FDA-approved.

MEDVi structures the tablet as an add-on to injection pricing, creating the highest recurring cost in this comparison ($369/month after the first month's $249 introductory-rate total). The model works for patients already on MEDVi injection who want an oral option without switching providers, but the $70 surcharge makes it less cost-competitive as a standalone oral choice. First-month introductory discount ($179 injection + $70 = $249) lowers entry cost. Verified at checkout September 4, 2026. Compounded, 503A, not FDA-approved.

Eden delivers the lowest month-to-month recurring total ($198/month: $99 medication + $99 membership after first month's $39 introductory membership rate) with integrated coaching, labs, and support. The separation of medication and membership billing is transparent but creates two line items. Oral route and format availability are clinician- and state-dependent. 12-month cost is $2,316 (our calculation: $138 first-month introductory total + $198×11 refill), the lowest without prepayment. Compounded, 503A, not FDA-approved.

PlexusDx publishes a single capsule price with no membership, no dose increases, and flexible term length (month-to-month $289, six-month $249/month). The six-month 12-month total ($2,988, our calculation) is mid-range: lower than MEDVi, equal to Henry Meds month-to-month, higher than Eden and Henry Meds prepaid. The 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher, September 9, 2026) offers external service validation. Compounded, 503A, not FDA-approved.

Brand Wegovy pill (Ro, WeightWatchers Clinic, LifeMD) is FDA-approved with clinical trial support but requires separate medication and membership payments, fasting administration, and costs $198–$448/month combined depending on provider and dose. The brand product is appropriate when insurance covers it, when regulatory approval is a priority, or when compounded options are contraindicated.

Methodology and freshness

Pricing, product details, and terms were captured from provider websites and verified at checkout where noted between July 20, 2026, and September 4, 2026. Henry Meds, MEDVi, Eden, Ro, WeightWatchers Clinic, LifeMD, and ShedRx data captured September 4, 2026. PlexusDx pricing captured July 23, 2026; PlexusDx Trustpilot rating captured September 9, 2026 from trustpilot.com/review/plexusdx.com. All 12-month cost calculations, per-month prepaid equivalents, and combined membership-plus-medication totals are our calculations, labeled as such in the tables. We compare like-for-like plan structures (month-to-month vs month-to-month, prepaid vs prepaid) in both directions. Promotional first-month rates and prepaid-in-full figures are labeled explicitly and appear alongside standard refill or month-to-month rates so the recurring cost is transparent. We state competitor advantages plainly where evidence supports them and note PlexusDx limitations where they exist. Readers should confirm all prices, terms, route availability, and eligibility at provider checkout, as promotional rates, prepaid offers, and product availability may change. This article was published September 21, 2026.

Frequently Asked Questions

What is the difference between sublingual semaglutide and oral semaglutide capsules?

Sublingual semaglutide dissolves under the tongue and absorbs through the mucous membrane directly into the bloodstream, bypassing the digestive tract. Oral semaglutide capsules are swallowed and absorb through the gastrointestinal system, subject to digestive enzymes and first-pass liver metabolism. Both are compounded formulations, not FDA-approved, and a licensed clinician determines which route is appropriate for each patient.

Is compounded oral semaglutide like Wegovy pill or Rybelsus?

No. Compounded oral and sublingual semaglutide are formulated by 503A compounding pharmacies for individual patients and are not FDA-approved. Wegovy pill and Rybelsus are FDA-approved brand products that use the absorption enhancer SNAC and require fasting administration. Compounded medications do not undergo FDA pre-market review for safety, effectiveness, or quality, and are distinct products with different formulations.

Which oral semaglutide option has the lowest monthly cost?

Eden offers the lowest recurring month-to-month rate at $198/month ($99 medication + $99 membership after the first month's $39 introductory membership rate), totaling $2,316 over 12 months (our calculation: $138 first-month introductory total + $198×11 refill). Henry Meds offers the lowest effective rate when prepaid: $149/month over 12 months ($1,788 paid in full upfront, our calculation). PlexusDx six-month plan costs $249/month ($2,988 over 12 months, our calculation), and MEDVi tablet surcharge creates the highest rate at $369/month refill ($4,308 over 12 months, our calculation).

Do all providers charge the same price at every semaglutide dose?

No. PlexusDx, Henry Meds, and MEDVi state that dose increases do not change the price. Brand Wegovy pill pricing is dose-dependent: starting doses cost $149/month, higher doses up to $299/month (Ro, WeightWatchers Clinic, LifeMD, captured September 4, 2026). Eden publishes one medication price ($99/month) with route and dose determined by the clinician. Confirm dose-related pricing at provider checkout.

Can I switch from semaglutide injection to an oral or sublingual form?

A licensed clinician determines whether switching from injection to oral or sublingual semaglutide is appropriate based on your medical history, current dose, tolerance, and treatment response. Some providers (Henry Meds, MEDVi, PlexusDx) offer both injection and oral options, allowing a potential route change within the same program. Clinical evidence for compounded oral and sublingual semaglutide is limited compared to FDA-approved injection, and individual absorption and outcomes may vary by formulation.

Sources

• Henry Meds website, compounded semaglutide injection and oral products (accessed September 4, 2026)
• MEDVi website and checkout verification, compounded semaglutide injection and tablet (accessed September 4, 2026)
• PlexusDx website, compounded semaglutide injection and oral capsules (accessed July 23, 2026)
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• Eden website, compounded semaglutide and tirzepatide oral availability (accessed September 4, 2026)
• Ro website, Wegovy pill and Body Program (accessed September 4, 2026)
• WeightWatchers Clinic website, Wegovy pill and Med+ program (accessed September 4, 2026)
• LifeMD website, Wegovy pill and membership (accessed September 4, 2026)
• ShedRx website, compounded oral drops/lozenges/tablets (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.